Acquisition Completed
US WorldMeds acquisition of Orbus Therapeutics
Announced Oct 2026 (approx.)
Advisers
Orbus Therapeutics
Target
Not disclosed
US WorldMeds
Acquirer
Not disclosed
Other advisers
- Financial adviser
- Target
- Orbus Therapeutics
- Acquirer
- US WorldMeds
- Target based in
- United States
- Buyer based in
- United States
- Completed
- 27 Oct 2026
- Sector
- Pharma
- Tags
- Pharma, Oncology, Rare Disease
In the league tables
Similar deals
- Grünenthal acquisition of Stivarga (regorafenib) Sep 2026 · US$433m · Pharma
- LEO Pharma acquisition of global rights for MT-7117 (dersimelagon) Aug 2026 · US$435m · Pharma
- Vertex Pharmaceuticals acquisition of Crinetics Pharmaceuticals Jul 2026 · US$10bn · Biotech
- SERB Pharmaceuticals acquisition of Exclusive development and commercialisation rights to Idefirix in Europe and MENA May 2026 · US$134m · Pharma
- Quince Therapeutics acquisition of Orphai Therapeutics May 2026 · Biotech
